Your privacy is very important to us. When you visit our website, please agree to the use of all cookies. For more information about personal data processing, please go to Privacy Policy

d2_banpc.jpg d2_banph.jpg

Pipeline

Cardiovascular,Metabolic and Renal Diseases​​

Liver Diseases​

Other Therapeutic Areas​

Product

Target

Indication

Commercial Rights

Preclinical

IND-Enabling

Phase l

Phase ll

Phase lll

  • RBD1007​

    siRNA​

    Caspase 2

    NAION *

    Global

    Preclinical

    IND-Enabling

    Phase l

    Phase ll

    Phase lll

  • RBD8088​

    (RiboOncoSTARTM)​

    Undisclosed

    Glioma

    Global

    Preclinical

    IND-Enabling

    Phase l

    Phase ll

    Phase lll

  • RBD8076

    (RiboGalSTARTM)​

    Undisclosed

    HAE *

    Global

    Preclinical

    IND-Enabling

    Phase l

    Phase ll

    Phase lll

  • RBD4086/​
    RBD1100​

    (RiboGalSTARTM)​

    Undisclosed​

    Inflammatory Diseases

    Global

    Preclinical

    IND-Enabling

    Phase l

    Phase ll

    Phase lll

* NAION: Non-Arteritic Anterior Ischemic Optic Neuropathy; HAE: Hereditary Angioedema.

Welcome to contact us to explore
collaboration opportunities

Learn More